Eric A. Kaiser
6Patents
3h-index
8Co-inventors
42Inventor score
Filing activity: May 21, 2012 → Apr 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9855332B2 | Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels | Emerging Cross-Sectional Technologies | 18 | Active |
| US9708393B2 | Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers | Emerging Cross-Sectional Technologies | 18 | Active |
| US10266587B2 | Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers | Emerging Cross-Sectional Technologies | 12 | Active |
| US11325967B2 | Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light a version in subjects in need thereof, especially migraine sufferers | Emerging Cross-Sectional Technologies | 0 | Active |
| US11027018B2 | Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels | Emerging Cross-Sectional Technologies | 0 | Active |
| US10765746B2 | Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.